30 Oct 2023
36m
【股海撈斟】小米強勢依然 14577利潤豐厚｜醫藥板全線強勢 君實普利單抗為第一隻獲FDA批难的中國研發及生產的藥物｜藥明合聯分拆上市(30/10/2023)
InvesTalk 講投資
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.